useful guidelines and recommendations. For this special issue of the American Journal of Medical Genetics (part C), we have examined these guidelines by performing a structured literature search and reviewing the existing advice, including that of hallmark papers by Blake et al. (1998) and the clinical checklist published recently by Trider (see Figure 1 , (Trider, Arra-Robar, van Ravenswaaij-Arts, & Blake, 2017) ).
To date, no guidelines for cranial imaging in CHARGE syndrome have been published, but we see two important reasons why there is a need for such a guideline. First, in our experience and that of others, cranial imaging in individuals with CHARGE syndrome is often performed incompletely or with insufficient resolution. As a result, some of the cranial malformations occurring in CHARGE syndrome 
Genetics
CHARGE is a clinical diagnosis Bergman, Janssen, et al. (2011) ; Blake et al. (1998) ; Harris, Robert, Kallen (1997) ; Issekutz, Prasad, Smith, and Blake (2005) ; Verloes (2005) Yes CHD7 testing can confirm uncertain diagnosis in mildly affected patients Bergman, Janssen, et al. (2011) Yes CHD7 testing may be performed according to flow diagram Bergman, Janssen, et al. (2011) Yes A genome-wide array should be performed in patients with CHARGE syndrome but without a CHD7 mutation Corsten-Janssen et al. (2013) Yes Clinical genetics consultation is indicated, including options for prenatal diagnosis Bergman, Janssen, et al. (2011); Lalani, Hefner, Belmont, and Davenport (2012) 
Yes
Patients diagnosed with hypogonadotropic hypogonadism and anosmia should be screened for clinical features consistent with CHARGE syndrome Jongmans et al. (2009) Out of scope a Olfactory bulb hypoplasia and semicircular canal aplasia should be considered major signs for CHARGE syndrome Asakura et al. (2008) ; Sanlaville et al. (2006) Out of scope If a parent has any features of CHARGE syndrome, molecular genetic testing is appropriate if a CHD7 pathogenic variant has been identified in the proband Jongmans et al. (2008) Out of scope CHD7 analysis should be performed in patients with a 22q11.2 deletion phenotype without TBX1 haploinsufficiency Corsten-Janssen et al. (2013) Out of scope CHD7 analysis should be performed in patients with Kallmann syndrome who have at least two additional CHARGE features or semicircular canal anomalies Bergman et al. (2012) ; Costa-Barbosa et al. (2013) ; Jongmans et al. (2009) ; Marcos et al. (2014) Out of scope CHD7 should be included in massive parallel sequencing gene panels for diagnostics in syndromic heart defects Corsten-Janssen et al. (2014) Out of scope CHD7 analysis should not be performed routinely in patients with only atrial septal defect or conotrunctal heart defects Corsten-Janssen et al. (2014) Out of scope CHD7 analysis should not be performed in septo-optic dysplasia without features of CHARGE Gregory et al. (2013) Out of scope MLPA analysis is indicated if no causal CHD7 is mutation found (contrary to Bergman et al., 2008) Wincent et al. 
Where indicated, tracheotomy needs to be performed early to avoid hypoxic events Roger et al. (1999) No, too detailed Individualized evaluation of feeding behavior (incl. oral defensiveness) should be a part of the standard otolaryngologic and feeding team practice were noted first in animal models (e.g., cerebellar abnormalities (Yu et al., 2013) ) or were found only after structured evaluation of images of a series of individuals (Hoch et al., 2017) . Second, as individuals with CHARGE syndrome are at increased risk of postoperative airway complications, procedures under anesthesia should be combined as much as possible (Blake et al., 2009) . The need to improve imaging while reducing risks therefore warrants guidelines for performing neuro-imaging in an optimal and efficient way. Altogether, we argue that standardized recommendations for neuro-imaging protocols could contribute to clinical awareness of the heterogeneous cranial abnormalities involved in CHARGE syndrome and improve care.
| OVERVIEW OF GUIDELINES AND RECOMMENDATIONS FROM LITERATURE
A literature search using PubMed was performed on August 17, 2017 using the search string: ("CHARGE syndrome" OR "CHARGE association"
OR CHD7) AND (guideline* OR consensus OR recommend* OR "best practice" OR "surveillance"). This resulted in 112 hits, of which 42 contained usable guidelines or recommendations. A further 15 articles with guidelines or recommendations were found through an examination of the references. The resulting full list with recommendations is given in Supplemental Table S1 . We then categorized the guidelines and recommendations from the literature either by organ system or as "general" (see Table 1 ), then checked if they were included in the Trider checklist (see Figure 1 and Table 1 ).
Out of 73 formulated recommendations, 53 were covered by the Trider checklist or the accompanying paper. Of the other 20, only one is truly "missing" from the checklist: 12 were out of the scope of a clinical surveillance checklist, six were too detailed to be included, and one was a recommendation to not perform a test (adrenal evaluation).
The missing recommendation concerns the advice to parents, therapists and teachers to take into account visual field defects. A last recommendation was actually given in the Trider paper but not included in their checklist. Trider advises screening patients with 
CHD7 should be included in massive parallel sequencing gene panels for diagnostics in patients with syndromic heart defects Expert opinion Corsten-Janssen et al.
CHD7 analysis should not be performed routinely in patients with isolated atrial septal or conotrunctal heart defects Cohort of 46 patients, no CHD7 mutations Corsten-Janssen et al.
CHD7 analysis should not be performed in patients with septo-optic dysplasia or hypopituitarism without features of CHARGE syndrome
Cohort of 100 patients, no CHD7 mutations Gregory et al. (2013) MLPA, multiplex ligation-dependent probe amplification; TBX1, T-box 1 gene. CHARGE for cochlear implant surgery before the age of three, however the cochlear implant box in their checklist is not shaded for the "infancy" column. Our review indicates the Trider surveillance checklist is well-supported by literature with only minor omissions.
Recommendations regarding analysis for CHD7, the causative gene for CHARGE syndrome, are beyond the scope of the clinical checklist aimed at follow-up, but we have included a summary of these guidelines in Table 2 .
As we discussed in the introduction, there are currently no formal guidelines for cranial imaging even though we argue that cranial imaging is an important clinical tool that needs to be handled carefully. The guidelines we present here for cranial imaging in patients with CHARGE syndrome are based on previously published neuro-radiologic recommendations (Asakura et al., 2008; Bergman, Janssen, et al., 2011; Fujita et al., 2009; Gregory et al., 2013; Pinto et al., 2005; Vesseur, Free, et al., 2016 ) in addition to current insights in detectable neuro-radiologic abnormalities and anatomic variants in patients with CHARGE syndrome (see Table 3 ).
| DIAGNOSTIC VALUE OF CRANIAL IMAGING
Imaging of the semicircular canals is recommended in patients with an atypical presentation of the syndrome to decide whether CHD7 testing is warranted, or to confirm the clinical diagnosis when CHD7 testing reveals no or an unclassified variant (Bergman, Janssen, et al., 2011) . This is because aplasia or hypoplasia of the semicircular canals is present in 95% of individuals with a pathogenic variant in the CHD7 gene, making it one of its most prevalent clinical features (Abadie et al., 2000; Bauer, Goldin, & Lusk, 2002; Lemmerling et al., 1998; Morimoto et al., 2006; Tellier et al., 1998; Wiener-Vacher, Amanou, Denise, Narcy, & Manach, 1999) . The configuration of the labyrinth in CHARGE syndrome is typical: a malformed vestibule and aplastic or hypoplastic semicircular canals that is sometimes combined with cochlear malformation. These abnormalities can already be seen in fetal imaging (Tilea et al., 2006) and can, on their own, provide a valuable first clue toward diagnosis.
Arhinencephaly is another common feature in CHARGE syndrome (Legendre et al., 2012; Sanlaville et al., 2006 ) that can be observed in imaging. The olfactory nerves may be hypo-or aplastic, usually in combination with olfactory sulcus effacement. Other cranial nerves, particularly the facial and acoustic nerve, may also be hypo-or aplastic. List of MRI findings observed in CHARGE syndrome. This list is not exhaustive: rarer features include hydrocephalus and corpus callosum abnormalities. Additionally, secondary abnormalities due to (perinatal) asphyxia are fairly common. Note: it is usually not possible to conclusively diagnose aplasia of cranial nerves on cranial imaging, as very hypoplastic nerves may be missed.
3D CISS, constructive interference in steady state-a fast thin slice heavily T2 weighted sequence, also known as Fiesta, 3D T2TSE; FLAIR, fluid attenuated inversion recovery; MPRAGE, multi-planar reconstruction acquired gradient echo-an ultrafast gradient echo, also known as 3DTFE; STIR, short-T1 inversion recovery; MPR: multiplanar reconstruction.
a Siemens terminology is used in the table. data]. These observations thus suggest that clivus abnormalities may be used as an important additional diagnostic tool.
Lastly, orbital abnormalities such as microphthalmia and colobomata, and nasal abnormalities such as choanal atresia may also be seen on cranial MRI.
As summarized in Table 3, Middle ear pathology, such as dysplastic ossicles or an absent/ stenotic oval or round window, is seen on mastoid CT in over 70% of patients (Vesseur, Verbist, et al., 2016) . In some of these children a bone-anchored hearing aid (BAHA, sometimes known as BCD-bone conductive device) may be a good hearing solution. A BAHA allows the perception of sound by by-passing the middle ear, provided the cochlea and auditory nerve are intact (Reinfeldt, Hakansson, Taghavi, & Eeg-Olofsson, 2015) . Cochlear nerve hypoplasia or aplasia is seen relatively frequently in CHARGE (Holcomb, Rumboldt, & White, 2013) , which reduces the possibilities for CI. In these cases, auditory brain stem implantation may be an option, although hearing results appear to be less successful while the surgery is more extensive than for CI (Colletti, Colletti, Mandala, & Colletti, 2014) .
CT imaging also provides additional information about surgical landmarks for cochlear implantation, such as detailed information about the lateral semicircular canals, which serves as a landmark for mastoidectomy. Alternatively, an aberrant course of the facial nerve increases the risk of perioperative injury and may impede cochleostomy (Vesseur, Free, et al., 2016) . Vascular abnormalities may also hamper the surgical procedure. Vesseur, Free, et al. (2016) recently published a guideline on CI implantation in CHARGE that extensively covers preoperative imaging.
| Olfactory bulbs and puberty induction
Fetal studies found arhinencephaly in 36 of 40 (90%) fetuses with a confirmed pathogenic CHD7 variant (Legendre et al., 2012) . This is seen less often postnatally, although anosmia is diagnosed in approximately 80% of individuals with CHARGE syndrome (Bergman, Bocca, et al., 2011) . Bergman, Bocca, et al. (2011) showed that olfaction and spontaneous onset of puberty are correlated in CHARGE syndrome: all (11/11) patients with hypogonadotropic hypogonadism (HH) were unable to smell, whereas patients without HH had the ability to smell (4/4). This combination of symptoms is also seen in Kallmann syndrome and is explained by common factors that facilitate axon guidance for both olfactory and GnRH neurons (Yanicostas, Herbomel, Dipietromaria, & Soussi-Yanicostas, 2009 ).
The correlation of anosmia and HH enables prediction of HH in patients with CHARGE experiencing anosmia, which is useful because after the age of 3 months endocrinological assessment of HH is impossible until the onset of puberty. Therefore, in children for whom no endocrinological evaluation was performed before the age of 3 months, anosmia can help predict whether it will be necessary to induce puberty. As the formal evaluation of sense of smell is fairly involved and only possible from a (developmental) age of 5 years, and an impaired sense of smell can have many causes, radiological evidence of olfactory nerve/bulb aplasia or hypoplasia can aid in predicting patients at risk for HH. However, because olfactory imaging is not a perfect predictor of sense of smell, olfactory imaging alone is insufficient to determine HH status.
| Other brain abnormalities
MR imaging has revealed a variety of other brain abnormalities in CHARGE syndrome (Hoch et al., 2017) . In specific cases, the presence of brain abnormalities on MRI can explain a particular clinical feature in a patient. For instance, post-asphyxia damage may explain an otherwise unexpected severe developmental delay in a child with overall mild symptoms. However, predicting clinical symptoms from MRI abnormalities is more difficult. For instance, even though cerebellar dys-or hypoplasia is fairly common in CHARGE syndrome (Yu et al., 2013) , no relationship to ataxia has been reported so far (Sohn et al., 2016) .
Research on the clinical relevance of cerebellar anomalies is ongoing.
FIGURE 3 Guideline for CT and MR imaging in CHARGE syndrome
Since the identification of CHD7 as the causal gene for CHARGE syndrome, several animal models have been developed, with mouse models being the most-studied. This has led to the identification in mice of significant anatomical features that were not known or were only anecdotally described in individuals with CHARGE syndrome. The best example for this is the hypoplasia of the cerebellar vermis. Abnormalities of the cerebellum were sporadically mentioned in papers on CHARGE syndrome, but it was only after the identification in mice of a role for Chd7 in the isthmic organizer that a systemic study of human MRI scans revealed cerebellar abnormalities in at least half of individuals with CHARGE syndrome (Haldipur & Millen, 2013; Yu et al., 2013) . Jiang et al. (2012) described telencephalic midline abnormalities in a mouse model with a nonsense Chd7 mutation. These mice had arhinencephaly, dilated third and lateral ventricles, reduced cerebral cortex, and corpus callosum crossing failure. As described above, arhinencephaly is a well-known CHARGE feature, but it was not until recently that ventriculomegaly and corpus callosum abnormalities were described in patients with CHARGE (Hoch et al., 2017; Jiang et al., 2012) . Sperry et al. (2014) found several phenotypic features that are well-known in humans with CHARGE syndrome in Foxg1 and Wnt1 conditional knockout mice, but they also observed skull bone abnormalities such as frontal, parietal and occipital bone dysplasia and hypoplasia of the maxilla (Sperry et al., 2014) . The same abnormalities were not seen in heterozygous Chd7 mice and have not been described in humans, but as described above, clivus and petrosal abnormalities are common in individuals with CHARGE syndrome.
Inner and middle ear abnormalities (os petrosum) have been studied extensively in humans and mice because of their effect on hearing. Therefore, most anatomic anomalies seen in Chd7-deficient mice had already been extensively documented in individuals with CHARGE syndrome. One lesser-known feature, however, is the otosclerosis-like fusion of the stapes footplate to the cochlear oval window as described by Ogier et al. (2014) in Looper mice. A recent study of CT images of the os petrosum of individuals with CHARGE syndrome showed that, in addition to the (known) abnormalities of the oval window, the stapes was dysplastic or not identifiable in half of the ears with a stenotic oval window (Vesseur, Verbist, et al., 2016) .
It is obvious that researchers studying animal models are 
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